We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 31 januari 2018

Latest content from npj Schizophrenia: 31 January 2018

If you are unable to see the message below, click here to view.
npj Schizophrenia

An interdisciplinary journal dedicated to publishing high-quality open research relevant to all aspects of schizophrenia and psychosis.
Explore the benefits of submitting your next research article.

Table of Contents: January 2018

Review Article | 10 January 2018

The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis

Janna de Boer, Merel Prikken, Wan U. Lei, Marieke Begemann & Iris Sommer

npj Schizophrenia 4 , Article number: 1 |  doi: 10.1038/s41537-017-0043-3

Your email address is in the npj Schizophrenia mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature